ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 145 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2021. The put-call ratio across all filers is 2.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $880 | -17.9% | 400 | 0.0% | 0.00% | – |
| Q1 2024 | $1,072 | -10.4% | 400 | 0.0% | 0.00% | – |
| Q4 2023 | $1,196 | +205.1% | 400 | 0.0% | 0.00% | – |
| Q3 2023 | $392 | -30.0% | 400 | 0.0% | 0.00% | – |
| Q2 2023 | $560 | -49.7% | 400 | -42.9% | 0.00% | – |
| Q1 2023 | $1,113 | -55.3% | 700 | +75.0% | 0.00% | -100.0% |
| Q4 2022 | $2,492 | -16.9% | 400 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $3,000 | 0.0% | 400 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $3,000 | +50.0% | 400 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $2,000 | 0.0% | 400 | 0.0% | 0.00% | – |
| Q4 2021 | $2,000 | -60.0% | 400 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $5,000 | -37.5% | 400 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $8,000 | -27.3% | 400 | 0.0% | 0.00% | -33.3% |
| Q1 2021 | $11,000 | +10.0% | 400 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $10,000 | -33.3% | 400 | 0.0% | 0.00% | -40.0% |
| Q3 2020 | $15,000 | -28.6% | 400 | 0.0% | 0.01% | -28.6% |
| Q2 2020 | $21,000 | +61.5% | 400 | 0.0% | 0.01% | +40.0% |
| Q1 2020 | $13,000 | -56.7% | 400 | -20.0% | 0.01% | -44.4% |
| Q4 2019 | $30,000 | +66.7% | 500 | 0.0% | 0.01% | +50.0% |
| Q3 2019 | $18,000 | -21.7% | 500 | 0.0% | 0.01% | -14.3% |
| Q2 2019 | $23,000 | +15.0% | 500 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $20,000 | -13.0% | 500 | 0.0% | 0.01% | -12.5% |
| Q4 2018 | $23,000 | +4.5% | 500 | 0.0% | 0.01% | 0.0% |
| Q3 2018 | $22,000 | +10.0% | 500 | 0.0% | 0.01% | +14.3% |
| Q2 2018 | $20,000 | -44.4% | 500 | 0.0% | 0.01% | -50.0% |
| Q1 2018 | $36,000 | -39.0% | 500 | -44.4% | 0.01% | -36.4% |
| Q4 2017 | $59,000 | +31.1% | 900 | 0.0% | 0.02% | +22.2% |
| Q3 2017 | $45,000 | +7.1% | 900 | 0.0% | 0.02% | +5.9% |
| Q2 2017 | $42,000 | – | 900 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 1,275,000 | $45,020,000 | 9.84% |
| Aviva Holdings Ltd. | 340,100 | $12,009,000 | 5.60% |
| Aisling Capital LLC | 837,125 | $29,559,000 | 5.38% |
| RA Capital Management | 704,701 | $24,883,000 | 3.05% |
| Rhenman & Partners Asset Management AB | 543,347 | $19,186,000 | 3.04% |
| BB BIOTECH AG | 1,408,542 | $49,736,000 | 1.63% |
| Antipodean Advisors LLC | 91,000 | $3,213,000 | 1.57% |
| Iguana Healthcare Management, LLC | 75,000 | $2,648,000 | 1.31% |
| Crawford Lake Capital Management, LLC | 93,551 | $3,303,000 | 1.31% |
| FT Options LLC | 22,834 | $806,000 | 1.06% |